Substituent Effects on Drug–Receptor H-bond Interactions: Correlations Useful for the Design of Kinase Inhibitors

作者: Brian G. Lawhorn , Joanne Philp , Alan P. Graves , Dennis A. Holt , Gregory J. Gatto

DOI: 10.1021/ACS.JMEDCHEM.6B01342

关键词:

摘要: Investigation of troponin I-interacting kinase (TNNI3K) as a potential target for the treatment heart failure has produced series substituted N-methyl-3-(pyrimidin-4-ylamino)benzenesulfonamide inhibitors that display excellent potency and selectivity against broad spectrum protein kinases. Crystal structures prototypical members bound to ATP-binding site TNNI3K reveal two anchoring hydrogen bond contacts: (1) from hinge region amide N–H pyrimidine nitrogen (2) sulfonamide gatekeeper threonine. Evaluation various para-substituted benzenesulfonamides defined substituent effect on binding affinity resulting modulation H-bond donor strength. An opposite electronic emerged NH-pyrimidine interaction, which is further illuminated in correlation calculated acceptor strength variety heterocycles. These fundamental correlations drug–receptor H...

参考文章(41)
David J. Huggins, Woody Sherman, Bruce Tidor, Rational approaches to improving selectivity in drug design. Journal of Medicinal Chemistry. ,vol. 55, pp. 1424- 1444 ,(2012) , 10.1021/JM2010332
A S Abramovitz, V Massey, Interaction of phenols with old yellow enzyme. Physical evidence for charge-transfer complexes. Journal of Biological Chemistry. ,vol. 251, pp. 5327- 5336 ,(1976) , 10.1016/S0021-9258(17)33165-4
Laurent F. Hennequin, Andrew P. Thomas, Craig Johnstone, Elaine S. E. Stokes, Patrick A. Plé, Jean-Jacques M. Lohmann, Donald J. Ogilvie, Mike Dukes, Steve R. Wedge, Jon O. Curwen, Jane Kendrew, Christine Lambert-van der Brempt, Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors. Journal of Medicinal Chemistry. ,vol. 42, pp. 5369- 5389 ,(1999) , 10.1021/JM990345W
Michael H. Abraham, Philip P. Duce, David V. Prior, Derek G. Barratt, Jeffrey J. Morris, Peter J. Taylor, Hydrogen bonding. Part 9. Solute proton donor and proton acceptor scales for use in drug design Journal of The Chemical Society-perkin Transactions 1. pp. 1355- 1375 ,(1989) , 10.1039/P29890001355
Gopalan Soman, Jayashree Narayanan, Bruce L. Martin, Donald J. Graves, Use of substituted (benzylidineamino)guanidines in the study of guanidino group-specific ADP-ribosyltransferase Biochemistry. ,vol. 25, pp. 4113- 4119 ,(1986) , 10.1021/BI00362A019
Barth�l�my Nyasse, Leif Grehn, Ulf Ragnarsson, Hernani L. S. Maia, Luis S. Monteiro, Ivo Leito, Ilmar Koppel, Juta Koppel, Synthesis and cathodic cleavage of a set of substituted benzenesulfonamides including the corresponding tert-butyl sulfonylcarbamates: pK a of sulfonamides Journal of the Chemical Society, Perkin Transactions 1. pp. 2025- 2031 ,(1995) , 10.1039/P19950002025
Caterina Bissantz, Bernd Kuhn, Martin Stahl, A Medicinal Chemist’s Guide to Molecular Interactions Journal of Medicinal Chemistry. ,vol. 53, pp. 5061- 5084 ,(2010) , 10.1021/JM100112J
F. Anthony Romero, Inkyu Hwang, Dale L. Boger, Delineation of a Fundamental α-Ketoheterocycle Substituent Effect for Use in the Design of Enzyme Inhibitors Journal of the American Chemical Society. ,vol. 128, pp. 14004- 14005 ,(2006) , 10.1021/JA064522B
Cesare Gennari, Markus Gude, Donatella Potenza, Umberto Piarulli, Hydrogen‐Bonding Donor/Acceptor Scales in β‐Sulfonamidopeptides Chemistry: A European Journal. ,vol. 4, pp. 1924- 1931 ,(1998) , 10.1002/(SICI)1521-3765(19981002)4:10<1924::AID-CHEM1924>3.0.CO;2-P